Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05584241 · ClinicalTrials.gov registry record · NA

Behavioral Change Following Alzheimer's Disease (AD) Biomarker Disclosure

A NA study of Alzheimer Disease and Mild Cognitive Impairment, sponsored by University of Michigan.

Active
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT05584241 is a NA study of Alzheimer Disease and Mild Cognitive Impairment that is active but no longer recruiting, run by University of Michigan. The registered enrollment target is 100 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05584241, a NA study of Alzheimer Disease and Mild Cognitive Impairment, is active but no longer recruiting, sponsored by University of Michigan.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

The proposed project will assess long-term changes to health/lifestyle, advanced planning, and research engagement that Black and White patients with Amnestic Mild Cognitive Impairment (aMCI) make following disclosure of positron emission tomography-based amyloid and tau burden and associated risk of conversion to Dementia-Alzheimer's Type. Healthcare access will be explored as potential barrier to or facilitator of behavior change.

Conditions Studied

Alzheimer Disease Mild Cognitive Impairment Amnestic Mild Cognitive Disorder

Interventions

  • BEHAVIORAL Diagnostic Disclosure Protocol
  • BEHAVIORAL Biomarker Disclosure Protocol

Study Locations (1)

Michigan

  • The University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-02-20
Est. Completion 2026-05
Phase NA

Sponsor

University of Michigan

1,327 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05584241

The ClinicalTrials.gov registry entry for NCT05584241 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (96% lower). The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Diagnostic Disclosure Protocol is the first listed.

NCT05584241 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT05584241 about?

NCT05584241 is a clinical study titled "Behavioral Change Following Alzheimer's Disease (AD) Biomarker Disclosure". The proposed project will assess long-term changes to health/lifestyle, advanced planning, and research engagement that Black and White patients with Amnestic Mild Cognitive Impairment (aMCI) make following disclosure of positron emission tomography-based amyloid and tau burden and associated risk o...

What is the current status of trial NCT05584241?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-02-20. Estimated completion is 2026-05.

What conditions does trial NCT05584241 study?

This clinical trial studies the following conditions: Alzheimer Disease, Mild Cognitive Impairment, Amnestic Mild Cognitive Disorder.

What interventions are being tested in trial NCT05584241?

The interventions under investigation include: Diagnostic Disclosure Protocol (BEHAVIORAL), Biomarker Disclosure Protocol (BEHAVIORAL).

Who is sponsoring clinical trial NCT05584241?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05584241 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Alzheimer Disease

All registered trials for this condition

Mild Cognitive Impairment

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.